David E. Leaf

14.7k citations
155 papers · 9.9k · 5 hit papers · h-index 48

Impact in

  • Nephrology top 0.2%
    • Acute Kidney Injury Research
    • Parathyroid Disorders and Treatments
    • COVID-19 Clinical Research Studies
    • SARS-CoV-2 and COVID-19 Research

Papers in

    • Acute Kidney Injury Research 20
    • Parathyroid Disorders and Treatments 16
    • Chronic Kidney Disease and Diabetes 7
    • COVID-19 Clinical Research Studies 18

David E. Leaf

151 papers receiving 9.6k citations

David E. Leaf's Hit Papers

Target Trial Emulation 2022 · 567 citations
5670+3+6Years since publication250500750

Peers

David E. Leaf
Comparison fields: 5 of 157
  • Nephrology 1.8k
  • Infectious Diseases 2.1k
  • Critical Care and Intensive Care Medicine 377
  • Oncology 1.8k
  • Internal Medicine 240
Replace David M. Charytan with:
David M. Charytan United States
Shruti Gupta United States
Salim S. Hayek United States
Laurie A. Tomlinson United Kingdom
Natalie Staplin United Kingdom
Marianna Adamo Italy
Anitha Vijayan United States
Nigel John Brunskill United Kingdom
William G. Herrington United Kingdom
Steven N. Fishbane United States
David E. Leaf relative to David M. Charytan United States David M. Charytan's profile →
Citations per field
00.5×2×2.8×
David M. Charytan · 1×
Citations per year

Countries citing papers authored by David E. Leaf

Since Specialization
Citations

This map shows the geographic impact of David E. Leaf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David E. Leaf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David E. Leaf more than expected).

Fields of papers citing papers by David E. Leaf

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David E. Leaf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David E. Leaf. The network helps show where David E. Leaf may publish in the future.

Co-authors

The 25 scholars most cited alongside David E. Leaf, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David E. Leaf Line = papers co-authored together David E. Leaf links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 155 papers — load more, or switch the sort, to bring in the rest.

#Work
1
COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection
Hit paper breakdown →
2020996
2
Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the US
Hit paper breakdown →
2020727
3
Target Trial Emulation
Hit paper breakdown →
2022567
4
Clinicopathological features of acute kidney injury associated with immune checkpoint inhibitors
Hit paper breakdown →
2016513
5 2020386
6 2018302
7
Clinical Features and Outcomes of Immune Checkpoint Inhibitor–Associated AKI: A Multicenter Study
Hit paper breakdown →
2020300
8 2019229
9 2020211
10 2006185
11 2020178
12 2020176
13 2021171
14 2021163
15 2021160
16 2013157
17 2021154
18 2020141
19 2008131
20 2014120

About David E. Leaf

David E. Leaf is a scholar working on Nephrology, Infectious Diseases, Genetics, Oncology and Hematology, having authored 155 papers that have together received 9.9k indexed citations. Recurring topics across this work include Acute Kidney Injury Research (20 papers), COVID-19 Clinical Research Studies (18 papers), Parathyroid Disorders and Treatments (16 papers), Cancer Immunotherapy and Biomarkers (14 papers), Hemoglobinopathies and Related Disorders (7 papers), Chronic Kidney Disease and Diabetes (7 papers), Renal Transplantation Outcomes and Treatments (6 papers) and Chemotherapy-induced organ toxicity mitigation (6 papers). The work is most often cited by research in Nephrology (1.8k citations), Infectious Diseases (2.1k citations), Critical Care and Intensive Care Medicine (377 citations), Oncology (1.8k citations) and Internal Medicine (240 citations). David E. Leaf has collaborated with scholars based in United States, Netherlands and Canada. Frequent co-authors include Miguel Ángel Hernán, Wei Wang, Shruti Gupta, Sushrut S. Waikar, David S. Goldfarb, Hanny T. Al-Samkari, Marta Christov, Pavan K. Bendapudi, Larissa Bornikova and Annemarie E. Fogerty. Their work appears in journals such as Kidney International, Journal of the American Society of Nephrology, American Journal of Kidney Diseases, Clinical Journal of the American Society of Nephrology and JAMA.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact